VANGUARD GROUP INC

Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Symbol: CRNX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 9.31M shares
Security Ownership: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Crinetics Pharmaceuticals, Inc. Common Stock (CRNX)

2025-04-07 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.31M shares of Crinetics Pharmaceuticals, Inc. Common Stock (CRNX). This represents 10% percent ownership of the company. In their previous filing dated 2025-01-30, VANGUARD GROUP INC had reported owning 9.09M shares, indicating an increase of 2.44% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	10%	+2%	$312M	9.31M	+222,209	+2.44%	$33.54	13G/A	3/31/2025	7 Apr 2025 11:52:11
The Vanguard Group	9.8%		$305M	9.09M			$33.54	13G/A	12/31/2024	30 Jan 2025 21:33:19

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.01%	+0%	$465M	9.09M	+2,801,736	+44.6%	$51.13	Q4 2024
9/30/2024	0.01%	+0%	$321M	6.29M	+1,773,177	+39.3%	$51.10	Q3 2024
6/30/2024	0%	+0%	$202M	4.51M	+939,402	+26.3%	$44.79	Q2 2024
3/31/2024	0%	+0%	$167M	3.58M	+72,624	+2.07%	$46.81	Q1 2024
12/31/2023	0%	+0%	$125M	3.5M	+95,417	+2.8%	$35.58	Q4 2023
9/30/2023	0%	+0%	$101M	3.41M	+674,301	+24.7%	$29.74	Q3 2023
6/30/2023	0%	+0%	$49.2M	2.73M	+39,672	+1.47%	$18.02	Q2 2023
3/31/2023	0%	+0%	$43.3M	2.69M	+306,675	+12.9%	$16.06	Q1 2023
12/31/2022	0%	+0%	$43.7M	2.39M	+29,740	+1.26%	$18.30	Q4 2022
9/30/2022	0%	0%	$46.3M	2.36M	-87,867	-3.59%	$19.64	Q3 2022
6/30/2022	0%	+0%	$45.6M	2.44M	+345,201	+16.4%	$18.65	Q2 2022
3/31/2022	0%	+0%	$46.1M	2.1M	+2,415	+0.12%	$21.95	Q1 2022
12/31/2021	0%	+0%	$59.6M	2.1M	+421,017	+25.1%	$28.41	Q4 2021
9/30/2021	0%	+0%	$35.3M	1.68M	+173,044	+11.5%	$21.05	Q3 2021
6/30/2021	0%	+0%	$28.3M	1.5M	+338,920	+29.1%	$18.85	Q2 2021
3/31/2021	0%	+0%	$17.8M	1.16M	+11,659	+1.01%	$15.28	Q1 2021
12/31/2020	0%	+0%	$16.3M	1.15M	+71,160	+6.58%	$14.11	Q4 2020
9/30/2020	0%		$16.9M	1.08M	+62	+0.01%	$15.67	Q3 2020
6/30/2020	0%	+0%	$18.9M	1.08M	+572,819	+113%	$17.52	Q2 2020
3/31/2020	0%	+0%	$7.47M	508K	+4,216	+0.84%	$14.70	Q1 2020
12/31/2019	0%		$12.6M	504K	-100	-0.02%	$25.09	Q4 2019
9/30/2019	0%		$7.58M	504K	-438	-0.09%	$15.04	Q3 2019
6/30/2019	0%	+0%	$12.6M	505K	+52,327	+11.6%	$25.00	Q2 2019
3/31/2019	0%	+0%	$10.3M	452K	+179,489	+65.8%	$22.76	Q1 2019
12/31/2018	0%	+0%	$8.18M	273K	+24,800	+10%	$29.99	Q4 2018
9/30/2018	0%	+0%	$7.1M	248K	+247,923	NEW	$28.65	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.